In Dr. Ling-Jian Meng's lab at the University of Illinois, researchers are developing advanced imaging technology to explore brain functions. This work focuses on creating a new SPECT imaging system that will allow for detailed visualization of various brain activities by using different tracers. The goal is to understand how blood flow, oxygen levels, and neuron metabolism work together in both healthy and diseased brains when subjected to different cognitive and physical challenges.

Dr. Haohua Tu's lab focuses on improving the success rates of assisted reproductive technologies (ART), like in vitro fertilization (IVF), through advanced imaging techniques. By developing a method called multiplexed optical metabolic imaging (MOMI), the lab aims to combine detailed insights into an embryo's structure and metabolism, which could lead to better assessments of embryo viability. Ultimately, this research could enhance the chances of successful pregnancies from embryo transfers, benefiting both humans and livestock.

Dr. Thomas Gaj's lab focuses on developing innovative gene-editing therapies for amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease caused by mutations in the SOD1 gene. Using a cutting-edge technique called CRISPR base editing, the lab aims to safely and effectively turn off the production of harmful mutant proteins in the nervous system. Their work not only targets ALS but also paves the way for potential treatments for other neurological disorders.

Dr. Bumsoo Han's lab focuses on developing new treatment strategies for pancreatic ductal adenocarcinoma (PDAC) by altering the tumor's surrounding environment, known as the stroma. The researchers are investigating the role of the coagulation system in the tumor microenvironment and how targeting specific components can enhance drug delivery and combat resistance. By understanding these interactions, the lab aims to improve therapeutic outcomes for patients with pancreatic cancer.

Dr. Brendan A. Harley's lab focuses on developing advanced biomaterials to study two significant areas: the generation of blood and immune cells from stem cells in the bone marrow and the mechanisms driving the initiation of endometriosis lesions. By creating tissue engineering models that mimic the body's natural processes, the lab aims to enhance our understanding of hematopoiesis and endometrioma formation. This research has important implications for improving treatments for blood disorders and endometriosis, which are major health issues.

Dr. Zhi-Pei Liang's lab at the University of Illinois focuses on developing advanced imaging technologies to better understand brain diseases. Their innovative work involves creating a new imaging method that can capture multiple brain characteristics at once, allowing for faster and more detailed assessments of brain health. This research is aimed at improving diagnoses and treatment strategies in personalized medicine.

Dr. Michael Oelze's lab at the University of Illinois focuses on advancing ultrasound technology by developing a low-cost, high-channel count research platform for 3D volumetric imaging. Their work aims to make real-time and ultrafast imaging more accessible for research and clinical applications. By creating a user-friendly and open-source platform, the lab hopes to improve the quality and affordability of advanced ultrasound techniques.

Dr. Andrew Smith's lab focuses on developing innovative delivery systems for cancer therapies and obesity management. They are particularly interested in using nanocarriers for targeted treatment of metastatic breast cancer and advancing blood-based diagnostics for prostate cancer. Their work aims to improve health outcomes through personalized medicine by harnessing the body’s immune responses and minimizing side effects.

Dr. Fan Lam's lab focuses on developing advanced mass spectrometry techniques to study Alzheimer’s Disease. The research aims to create detailed molecular maps of the brain to better understand how brain chemistry changes in response to the disease and how neurogenesis might play a role in neuronal vulnerability and disease progression. By addressing the biochemical changes that occur in Alzheimer's, the lab hopes to identify potential biomarkers and therapeutic targets for this critical health issue.

Dr. Cunjiang Yu's lab at the University of Illinois focuses on developing innovative materials that support bone healing and regeneration. The lab's research looks into how light and electrically active materials can enhance the body's natural processes for repairing bone. By creating new biocompatible composites that combine citrate and electrosimulation, they aim to improve the effectiveness of orthopedic treatments.

Dr. Hua Wang's lab at the University of Illinois focuses on innovative approaches to modify and tag red blood cells (RBCs) for various biomedical applications. They aim to develop methods that allow for the direct engineering of RBCs in living organisms, which can enhance drug delivery, imaging, and immune responses. By leveraging the natural capabilities of RBCs, the research has the potential to transform how we use these cells in medicine.

Professor Brian T. Cunningham's research lab focuses on developing an innovative system for testing viral infections such as HIV, Hepatitis B, and Hepatitis C using a compact and cost-effective device. Their goal is to create a rapid, easy-to-use test that can be performed at point-of-care sites, providing results in less than 30 minutes with minimal blood samples. This work aims to improve access to accurate viral load monitoring, which is crucial for managing these infections.